PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA

Resumen del producto

About PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA

PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA is a medication designed for extended-release, intended for the management of moderate to severe pain. This product contains tapentadol hydrochloride as its active ingredient.

Key Benefits & Uses

• Provides extended relief from moderate to severe pain, allowing for better management of chronic pain conditions.
• The extended-release formulation ensures a consistent level of medication in the body throughout the day, reducing the need for frequent dosing.
• May help improve the quality of life for individuals suffering from chronic pain by providing effective pain relief and allowing them to engage in daily activities more comfortably.

Active Ingredient & Action

The active ingredient in PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA is tapentadol hydrochloride. Tapentadol is a synthetic opioid analgesic that works by binding to the mu-opioid receptors in the brain, spinal cord, and other tissues to reduce pain perception.

Important Notes

PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA should be used under the supervision of a healthcare professional. It may cause side effects such as nausea, dizziness, constipation, and headache. Inform your doctor if you have any allergies or other medical conditions before starting this medication. Do not drive or operate machinery until you know how PALEXIA RETARD affects you. This product is not intended for use in children under 18 years of age.

Inactive Ingredients

The inactive ingredients in PALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADA include microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, and other excipients. For a complete list of inactive ingredients, consult the product packaging or contact the manufacturer.